- Despite environmental concerns, plastics become dominant materials used in medical devices
MOUNTAIN VIEW, California, Sept. 25, 2012 /PRNewswire/ -- The increasing average age of the U.S. population is creating a vast market for medical treatment, especially minimally invasive procedures. In a fragile economy, patients prefer minimally invasive methods, boosting the consumption of plastic polymers, which are ideal for use in catheters and medical tubing.
A new comprehensive Frost & Sullivan (http://www.chemicals.frost.com) study Analysis of the Plastic Polymers in Medical Devices Market, finds that the total North American market volume of plastics in medical devices totalled 1,370.0 million pounds, corresponding to revenues in excess of $1 billion. By 2018, revenues are expected to equal $1.45 billion, fuelled by a compound annual growth rate of 5.2 percent. Commodity plastics such as polyvinyl chloride (PVC), polyethylene (PE) and polypropylene (PP) accounted for most of the total volume.
If you are interested in more information on this research, please send an email to Jeannette Garcia, Corporate Communications, at email@example.com, with your full name, company name, title, telephone number, company email address, company website, city, state, and country.
"While the baby boomer population has surpassed 76 million, the number of young people requiring medical care is also on the rise," said Shomik Majumdar, Vice President, Chemicals and Materials. "The higher incidence of lifestyle diseases, along with governments' keener focus on improving healthcare, drives the demand for medical devices and consequently, plastic polymers."
Reduced hospital stay to lower healthcare costs will increase the focus on homecare medical devices and enhance the demand for dialysis kits and diabetes control devices. This will therefore augment the need for medical plastics. Plastics are preferred in homecare devices due to their flexibility, durability and light weight.
On the flip side, there are some concerns about the use of polymers in medical devices, especially in terms of degradability and recyclability. Nevertheless, this environmental issue has not reached a critical state. The low price of commodity resins like PE, PP, PVC and their high performance characteristics makes them irreplaceable in the near future.
"There has also been heightened focus on engineered polymers such as co-polyether-ester elastomers (COPE), polyether block amides (PEBA), and acetal chemistries that have more advanced performance properties for niche, technologically advanced healthcare applications, such tissue engineering and implants," said Research Analyst Tridisha Goswami. "These new materials will expand the scope of plastic polymers' application and propel the market."
Analysis of the Plastic Polymers in Medical Devices Market is part of the Chemicals & Materials Growth Partnership Services program that also includes research in construction & utility, food and animal nutrition, packaging, pharmaceuticals, cosmetics, transportation, and personal protection. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated extensive primary research across the industry value chain.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Analysis of the Plastic Polymers in Medical Devices Market
Corporate Communications – North America
SOURCE Frost & Sullivan